Headlines about Prism Medical (CVE:PM) have trended positive this week, InfoTrie reports. The research firm identifies positive and negative press coverage by reviewing more than six thousand news and blog sources. The firm ranks coverage of public companies on a scale of -5 to 5, with scores closest to five being the most favorable. Prism Medical earned a news sentiment score of 2.43 on their scale. InfoTrie also assigned press coverage about the company an news buzz score of 10 out of 10, meaning that recent press coverage is extremely likely to have an impact on the stock’s share price in the near future.
Prism Medical has a one year low of C$79.71 and a one year high of C$123.55.
About Prism Medical
Recommended Story: Hedge Funds – Risk or Reward?
Receive News & Ratings for Prism Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Prism Medical and related companies with MarketBeat.com's FREE daily email newsletter.